Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjolein Geurts

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Neuro-Oncology|April 9, 2024
Locoregional delivery of chimeric antigen receptor-T cells: Breaking the spell in glioblastoma?Marjolein Geurts, Matthias Preusser
Neuro-Oncology Practice|January 8, 2025
Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors: New drugs, new evidence, new guidelines, and new considerationsKatherine B Peters, Marjolein Geurts
Neuro-Oncology|April 17, 2020
Fast-growing oligodendrogliomas are aggressive tumors-the real life biomarker?Marjolein Geurts, Martin J van den Bent
Neuro-Oncology|August 29, 2021
Hypermutated recurrences: Identifying the clinical relevanceMarjolein Geurts, Martin J van den Bent
Cancer|December 5, 2018
On high-risk, low-grade glioma: What distinguishes high from low?Marjolein Geurts, Martin J van den Bent
Neuro-Oncology|May 17, 2018
Timing of radiotherapy in newly diagnosed glioblastoma: no need to rush?Marjolein Geurts, Martin J van den Bent
Nederlands Tijdschrift Voor Geneeskunde|December 13, 2012
[A man with impaired consciousness after femur fractures]Anna Maria Blokhuis, Marjolein Geurts, Dennis Johannes Nieuwkamp
Neuro-Oncology|April 30, 2025
Correlative Studies In Central Nervous System Tumors Clinical Trials: The Emerging Role Of Microbiome ResearchRaoull Hoogendijk, Marjolein Geurts, Jasper van der Lugt
Neuro-Oncology|June 10, 2024
Tumor growth in recurrent glioblastoma-RANO: when to plan the baseline scan?Lisa Dobber, Marjolein Geurts, Martin J van den Bent
Current Opinion in Oncology|August 30, 2021
Treatment of anaplastic gliomas: evidences and controversiesMarjolein Geurts, Tom J Snijders, Martin J van den Bent
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Neuro-Oncology|April 9, 2024
Locoregional delivery of chimeric antigen receptor-T cells: Breaking the spell in glioblastoma?Marjolein Geurts, Matthias Preusser
Neuro-Oncology Practice|January 8, 2025
Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors: New drugs, new evidence, new guidelines, and new considerationsKatherine B Peters, Marjolein Geurts
Neuro-Oncology|April 17, 2020
Fast-growing oligodendrogliomas are aggressive tumors-the real life biomarker?Marjolein Geurts, Martin J van den Bent
Neuro-Oncology|August 29, 2021
Hypermutated recurrences: Identifying the clinical relevanceMarjolein Geurts, Martin J van den Bent
Cancer|December 5, 2018
On high-risk, low-grade glioma: What distinguishes high from low?Marjolein Geurts, Martin J van den Bent
Neuro-Oncology|May 17, 2018
Timing of radiotherapy in newly diagnosed glioblastoma: no need to rush?Marjolein Geurts, Martin J van den Bent
Nederlands Tijdschrift Voor Geneeskunde|December 13, 2012
[A man with impaired consciousness after femur fractures]Anna Maria Blokhuis, Marjolein Geurts, Dennis Johannes Nieuwkamp
Neuro-Oncology|April 30, 2025
Correlative Studies In Central Nervous System Tumors Clinical Trials: The Emerging Role Of Microbiome ResearchRaoull Hoogendijk, Marjolein Geurts, Jasper van der Lugt
Neuro-Oncology|June 10, 2024
Tumor growth in recurrent glioblastoma-RANO: when to plan the baseline scan?Lisa Dobber, Marjolein Geurts, Martin J van den Bent
Current Opinion in Oncology|August 30, 2021
Treatment of anaplastic gliomas: evidences and controversiesMarjolein Geurts, Tom J Snijders, Martin J van den Bent
Pageof 6